ORBIMED ADVISORS LLC - 09 May 2025 SCHEDULE 13D/A Report for Edgewise Therapeutics, Inc. Common Stock (EWTX)

Filing Manager
ORBIMED ADVISORS LLC
Reporting Manager
ORBIMED ADVISORS LLC
Security
Edgewise Therapeutics, Inc. Common Stock
Symbol
EWTX
Shares outstanding
105,192,186 shares
Disclosed Ownership
15,252,867 shares
Ownership
14%
Form type
SCHEDULE 13D/A
Filing time
12 May 2025, 19:13:03 UTC
Date of event
09 May 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"ORBIMED ADVISORS LLC disclosed 14% ownership in Edgewise Therapeutics, Inc. Common Stock (EWTX) on 09 May 2025."

Quick Takeaways

  • ORBIMED ADVISORS LLC filed SCHEDULE 13D/A for Edgewise Therapeutics, Inc. Common Stock (EWTX).
  • Disclosed ownership: 14%.
  • Date of event: 09 May 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 12 May 2025, 19:13.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
ORBIMED ADVISORS LLC 14% 15,252,867 0 15,252,867 /s/ Carl L. Gordon Carl L. Gordon/Member 0001055951
ORBIMED CAPITAL GP VI LLC 14% 14,809,075 0 14,809,075 /s/ Carl L. Gordon Carl L. Gordon/Member of OrbiMed Advisors LLC (ORBIMED ADVISORS LLC, its managing member) 0001682115
OrbiMed Genesis GP LLC 0.4% 443,792 0 443,792 /s/ Carl L. Gordon Carl L. Gordon/Member of OrbiMed Advisors LLC (ORBIMED ADVISORS LLC, its managing member) 0001808744
ORBIMED CAPITAL LLC 0.3% 265,625 265,625 0 /s/ Carl L. Gordon Carl L. Gordon/Member 0001157524

Sponsored